Logo

Innovative Health Diagnostics, AIMA Partner on At-Home Endometriosis Test

Aug 23, 2022 | staff reporter

NEW YORK — Innovative Health Diagnostics said on Tuesday that it has partnered with Ontario-based AIMA Laboratories to develop a microRNA-based at-home test for endometriosis.

According to Innovative Health, the test detects miRNA biomarkers that are differentially expressed in women with endometriosis compared to women without the disease. Patients who receive a positive result from the blood test will be recommended for a laparoscopy, the Irvine, California-based company said.

Additional terms of the alliance were not disclosed.

Filed under

Molecular Diagnostics
Business News
Reproductive Health
endometriosis
North America
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.